10:09:20 EST Sun 26 Jan 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:ADMS - ADAMAS PHARMACEUTICALS INC - http://www.admsweb.com10:09:20 EST
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ADMS - Q2.85.45 · 5.520.15.45-0.56-9.3284.01,5782,2576.01  6.015  5.3812.57  3.3519:44:1210:0015 min RT 2¢

Recent Trades - Last 10 of 2257
Time ETExPriceChangeVolume
19:44:12Q5.52-0.49200
19:44:10Q5.52-0.49100
19:36:10Q5.52-0.49100
19:36:04Q5.52-0.49300
17:56:59Q5.45-0.565,200
16:18:39Q5.40-0.6120
16:00:04Q5.45-0.5615
16:00:00Q5.445-0.565100
16:00:00Q5.445-0.565139
16:00:00Q5.45-0.5612,385

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent BulletinsNews ReleasesIn The NewsOther
Date ETSymbolTypeHeadline
2020-01-24 10:00U:ADMSNews ReleaseINVESTOR ALERT: ADMS and BZUN: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders With Losses Exceeding $100K of Class Action Deadlines
2020-01-23 17:44U:ADMSNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS
2020-01-23 11:00U:ADMSNews ReleaseGlancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc.
2020-01-22 14:00U:ADMSNews ReleaseBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baozun, Adamas Pharmaceuticals, Cintas, and Correvio Pharma and Encourages Investors to Contact the Firm
2020-01-22 13:19U:ADMSNews ReleaseINVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Adamas Pharmaceuticals, and Exelon Corporation of Filing Deadlines
2020-01-21 17:50U:ADMSNews ReleaseADMS INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10th Deadline in Securities Class Action – ADMS
2020-01-17 00:00U:ADMSNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS
2020-01-16 11:00U:ADMSNews ReleaseGlancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc.
2020-01-15 16:33U:ADMSNews ReleaseBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baozun, Adamas Pharmaceuticals, Cintas, and Correvio Pharma and Encourages Investors to Contact the Firm
2020-01-14 16:03U:ADMSNews ReleaseROSEN, A LEADING LAW FIRM, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10th Deadline in Securities Class Action – ADMS
2020-01-13 13:13U:ADMSNews ReleaseINVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Adamas Pharmaceuticals, and Exelon Corporation of Filing Deadlines
2020-01-10 16:30U:ADMSNews ReleaseAdamas Announces New Employment Inducement Grant
2020-01-10 11:00U:ADMSNews ReleaseGlancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc.
2020-01-10 10:00U:ADMSNews ReleaseINVESTOR ALERT: ADMS and BZUN: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders With Losses Exceeding $100K of Class Action Deadlines
2020-01-09 15:00U:ADMSNews ReleaseBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Adamas Pharmaceuticals, Cintas, Correvio Pharma, and Exelon and Encourages Investors to Contact the Firm